156 related articles for article (PubMed ID: 19424681)
41. Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells.
Zhao J; Wang Q; Xu J; Zhao J; Liu G; Peng S
Eur J Pharmacol; 2011 Jun; 660(2-3):259-67. PubMed ID: 21497594
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
DU CY; El Harchi A; Zhang YH; Orchard CH; Hancox JC
J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1163-70. PubMed ID: 21489024
[TBL] [Abstract][Full Text] [Related]
43. Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
Kiesecker C; Zitron E; Lück S; Bloehs R; Scholz EP; Kathöfer S; Thomas D; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):423-35. PubMed ID: 15599706
[TBL] [Abstract][Full Text] [Related]
44. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
Guo J; Gang H; Zhang S
J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
[TBL] [Abstract][Full Text] [Related]
45. Effects of neferine on Kv4.3 channels expressed in HEK293 cells and ex vivo electrophysiology of rabbit hearts.
Wang C; Chen YF; Quan XQ; Wang H; Zhang R; Xiao JH; Wang JL; Zhang CT; Xiang JZ; Tang Q
Acta Pharmacol Sin; 2015 Dec; 36(12):1451-61. PubMed ID: 26592512
[TBL] [Abstract][Full Text] [Related]
46. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.
Katchman AN; McGroary KA; Kilborn MJ; Kornick CA; Manfredi PL; Woosley RL; Ebert SN
J Pharmacol Exp Ther; 2002 Nov; 303(2):688-94. PubMed ID: 12388652
[TBL] [Abstract][Full Text] [Related]
47. Curcumin inhibits hERG potassium channels in vitro.
Hu CW; Sheng Y; Zhang Q; Liu HB; Xie X; Ma WC; Huo R; Dong DL
Toxicol Lett; 2012 Jan; 208(2):192-6. PubMed ID: 22101212
[TBL] [Abstract][Full Text] [Related]
48. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
49. In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform.
Scholz EP; Alter M; Zitron E; Kiesecker C; Kathöfer S; Thomas D; Kreye VA; Kreuzer J; Becker R; Katus HA; Greten J; Karle CA
Toxicol Lett; 2006 Aug; 165(2):156-66. PubMed ID: 16647228
[TBL] [Abstract][Full Text] [Related]
50. Blockade of HERG human K+ channels and IKr of guinea-pig cardiomyocytes by the antipsychotic drug clozapine.
Lee SY; Kim YJ; Kim KT; Choe H; Jo SH
Br J Pharmacol; 2006 Jun; 148(4):499-509. PubMed ID: 16633353
[TBL] [Abstract][Full Text] [Related]
51. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
Schledermann W; Wulfsen I; Schwarz JR; Bauer CK
J Physiol; 2001 Apr; 532(Pt 1):143-63. PubMed ID: 11283231
[TBL] [Abstract][Full Text] [Related]
52. Effects of cariprazine on hERG 1A and hERG 1A/3.1 potassium channels.
Lee HJ; Choi BH; Choi JS; Hahn SJ
Eur J Pharmacol; 2019 Jul; 854():92-100. PubMed ID: 30954564
[TBL] [Abstract][Full Text] [Related]
53. Electrophysiologic characterization of a novel hERG channel activator.
Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
[TBL] [Abstract][Full Text] [Related]
54. The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph.
Chapman H; Pasternack M
Eur J Pharmacol; 2007 Jan; 554(2-3):98-105. PubMed ID: 17109852
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effects of neferine on Nav1.5 channels expressed in HEK293 cells.
Wang C; Wang H; Xiao JH; Wang JL; Xiang JZ; Tang Q
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):487-493. PubMed ID: 27465321
[TBL] [Abstract][Full Text] [Related]
56. State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy.
Ganapathi SB; Kester M; Elmslie KS
Am J Physiol Cell Physiol; 2009 Apr; 296(4):C701-10. PubMed ID: 19244476
[TBL] [Abstract][Full Text] [Related]
57. The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels.
Mbai M; Rajamani S; January CT
Cardiovasc Res; 2002 Sep; 55(4):799-805. PubMed ID: 12176129
[TBL] [Abstract][Full Text] [Related]
58. The EGFP/hERG fusion protein alter the electrophysiological properties of hERG channels in HEK293 cells.
Huang N; Lian JF; Huo JH; Liu LY; Ni L; Yang X; Zhou JQ; Li ZF; Song TS; Huang C
Cell Biol Int; 2011 Mar; 35(3):193-9. PubMed ID: 21143190
[TBL] [Abstract][Full Text] [Related]
59. Blockade of HERG human K+ channels by the antidepressant drug paroxetine.
Lee SH; Sung MJ; Lee HM; Chu D; Hahn SJ; Jo SH; Choe H; Choi BH
Biol Pharm Bull; 2014; 37(9):1495-504. PubMed ID: 25177033
[TBL] [Abstract][Full Text] [Related]
60. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
